Screening method for Salmonella enterica serovar Typhi and serovar Paratyphi A with reduced susceptibility to fluoroquinolones by PCR-restriction fragment length polymorphism

Microbiology and Immunology

Volumn 47, Issue 2, 2003, Pages 161-165

  Hirose, Kenji ^a   Tamura, Kazumichi ^a   Watanabe, Haruo ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Fluoroquinolone resistance; RFLP; Salmonella enterica serovar Paratyphi A; Salmonella enterica serovar Typhi

Indexed keywords

ASPARTIC ACID; CIPROFLOXACIN; QUINOLONE DERIVATIVE; SERINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL MUTATION; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; CODON; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; GENE; GENE GYRA; GENE MUTATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SALMONELLA ENTERICA; SCREENING TEST;

BACTERIA (MICROORGANISMS); NEGIBACTERIA; SALMONELLA; SALMONELLA ENTERICA; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHI;

EID: 0037284447     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2003.tb02800.x     Document Type: Article

References (20)

1. Brown, J.C., Shanahan, P.M., Jesudason, M.V., Thomson, C.J., and Amyes, S.G. 1996. Mutations responsible for reduced susceptibility to 4-quinolones in clinical isolates of multi-resistant Salmonella typhi in India. J. Antimicrob. Chemother. 37: 891-900.
2. Chitnis, V., Chitnis, D., Verma, S., and Hemvani, N. 1999. Multidrug-resistant Salmonella typhi in India. Lancet 354: 514-515.
3. Eykyn, S.J., and Williams, H. 1987. Treatment of multiresistant Salmonella typhi with oral ciprofloxacin. Lancet 2: 1407-1408.
4. Giraud, E., Brisabois, A., Martel, J.L., and Chaslus-Dancla, E. 1999. Comparative studies of mutations in animal isolates and experimental in vitro- and in vivo-selected mutants of Salmonella spp. suggest a counter selection of highly fluoroquinolone-resistant strains in the field. Antimicrob. Agents Chemother. 43: 2131-2137.
5. Hirose, K., Hashimoto, A., Tamura, K., Kawamura, Y., Ezaki, T., Sagara, H., and Watanabe, H. 2002. DNA sequence analysis of DNA gyrase and DNA topoisomerase IV quinolone resistance determining region of Salmonella enterica serovar Typhi and Paratyphi A. Antimicrob. Agents Chemother. 46: 3249-3252.
6. Hirose, K., Tamura, K., Sagara, H., and Watanabe, H. 2001. Antibiotic susceptibilities of Salmonella enterica serovar Typhi and S. enterica serovar Paratyphi A isolated from patients in Japan. Antimicrob. Agents Chemother. 45: 956-958.
7. Kato, J., Nishimura, Y., Imamura, R., Niki, H., Hiraga, S., and Suzuki, H. 1990. New topoisomerase essential for chromosome segregation in E. coli. Cell 63: 393-404.
8. Kato, J., Suzuki, H., and Ikeda, H. 1992. Purification and characterization of DNA topoisomerase IV in Escherichia coli. J. Biol. Chem. 267: 25676-25684.
9. Nakamura, S., Nakamura, M., Kojima, T., and Yoshida, H. 1989. gyrA and gyrB mutations in quinolone-resistant strains of Escherichia coli. Antimicrob. Agents Chemother. 33: 254-255.
10. Panigrahi, D., Roy, P., and Sehgal, R. 1991. Ciprofloxacin for typhoid fever. Lancet 338: 1601.
11. Parry, C., Wain, J., Chinh, N.T., Vinh, H., and Farrar, J.J. 1998. Quinolone-resistant Salmonella typhi in Vietnam. Lancet 351: 1289.
12. Rowe, B., Ward, L.R., and Threlfall, E.J. 1995. Ciprofloxacin-resistant Salmonella typhi in the UK. Lancet 346: 1302.
13. Rowe, B., Ward, L.R., and Threlfall, E.J. 1991. Treatment of multiresistant typhoid fever. Lancet 337: 1422.
14. Threlfall, E.J., Skinner, J.A., and Ward, L.R. 2001. Detection of decreased in vitro susceptibility to ciprofloxacin in Salmonella enterica serotypes Typhi and Paratyphi A. J. Antimicrob. Chemother. 48: 740-741.
15. Threlfall, E.J., and Ward, L.R. 2001. Decreased susceptibility to ciprofloxacin in Salmonella enterica serotype typhi, United Kingdom. Emerg. Infect. Dis. 7: 448-450.
16. Threlfall, E.J., Ward, L.R., Skinner, J.A., Smith, H.R., and Lacey, S. 1999. Ciprofloxacin-resistant Salmonella typhi and treatment failure. Lancet 353: 1590-1591.
17. Wang, F., Gu, X.J., Zhang, M.F., and Tai, T.Y. 1989. Treatment of typhoid fever with ofloxacin. J. Antimicrob. Chemother. 23: 785-788.
18. Yoshida, H., Bogaki, M., Nakamura, M., and Nakamura, S. 1990. Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli. Antimicrob. Agents Chemother. 34: 1271-1272.
19. Yoshida, H., Bogaki, M., Nakamura, M., Yamanaka, L.M., and Nakamura, S. 1991. Quinolone resistance-determining region in the DNA gyrase gyrB gene of Escherichia coli. Antimicrob. Agents Chemother. 35: 1647-1650.
20. Yoshida, H., Kojima, T., Yamagishi, J., and Nakamura, S. 1988. Quinolone-resistant mutations of the gyrA gene of Escherichia coli. Mol. Gen. Genet. 211: 1-7.